Latest Nasal EPAP Stories
THN3 Study Will Expand the Clinical Evidence for this Novel Neurostimulation Therapy for Moderate to Severe Obstructive Sleep Apnea SAN DIEGO, Nov.
Nierman Practice Management and Sleep Apnea MD have just launched their new service, OSA Referral Network Builder, to dentists across the country who want to build a strong referral network to
Latest research presented at 2014 American Academy of Otolaryngology Meeting in Orlando Sept. 19-23 MINNEAPOLIS and ORLANDO, Fla., Sept.
A new study shows a strong association between severe, untreated obstructive sleep apnea and the risk of elevated blood pressure despite the use of high blood pressure medications.
Theravent® Advanced Nightly Snore Therapy, a clinically proven therapy to reduce or eliminate snoring, proudly announces two new snoring therapies.
A new study with more than 8,500 Canadian patients revealed a link between obstructive sleep apnea (OSA) and the onset of diabetes. The study was the largest one of its kind to date and the results confirmed what earlier studies revealed with smaller and shorter follow-up periods.
Cases of obstructive sleep apnea are multiplying due to sedentary lifestyles and irregular sleep habits LONDON, June 4, 2014 /PRNewswire/ -- The increasingly sedentary lifestyle and
Theravent, Inc., a medical device company providing noninvasive solutions to help people stop snoring recently hit a milestone by exceeding 1 million nights of snoring treatment.
Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (CPAP) device reduced costs compared with in-laboratory testing and titration without negatively impacting clinical outcomes.
The global sleep apnea diagnostic devices market is broadly segmented into two categories, namely, Diagnostic Devices and Therapeutic Devices.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.